Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;30(1):136-140.
doi: 10.3201/eid3001.230924.

Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020

Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020

Emily Han et al. Emerg Infect Dis. 2024 Jan.

Abstract

We assessed tuberculosis (TB) diagnostic delays among patients with TB and COVID-19 in California, USA. Among 58 persons, 43% experienced TB diagnostic delays, and a high proportion (83%) required hospitalization for TB. Even when viral respiratory pathogens circulate widely, timely TB diagnostic workup for at-risk persons remains critical for reducing TB-related illness.

Keywords: COVID-19; California; SARS-CoV-2; TB; United States; bacteria; coronavirus disease; coronaviruses; deaths; diagnostic delay; hospitalization; respiratory infections; severe acute respiratory syndrome coronavirus 2; treatment outcomes; tuberculosis; viruses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of patients included in a study of TB diagnostic delays and treatment outcomes among patients with COVID-19, California, USA, 2020. TB high-burden counties included were Alameda (excluding the city of Berkeley), Los Angeles (excluding the cities of Long Beach and Pasadena), Orange, Sacramento, San Diego, and Santa Clara. Excluded cities maintain independent surveillance registries. *Includes TB patients also hospitalized for COVID-19. †Includes 3 patients with pleural TB only. TB, tuberculosis.
Figure 2
Figure 2
Timeline of 8 patients included in a study of TB diagnostic delays and treatment outcomes among patients with COVID-19, California, USA, 2020. Symptom onset is the date the first symptoms compatible with either TB or COVID-19 was identified. Symptom onset for patient 6 was in June 2019. Patient 7 was hospitalized for reasons unrelated to TB or COVID-19, and the TB diagnostic work-up was prompted by incidental findings on chest imaging. The healthcare visit of a missed opportunity to diagnose TB in a person with TB risk factors was a visit where >1 symptom or chest imaging finding was known. Yellow shading captures the number of days between the first missed opportunity and the first specimen collection for a TB diagnosis. Elevated COVID-19 incidence in California was considered >15 cases/100,000 population (7-day average rate). TB, tuberculosis.

References

    1. Deutsch-Feldman M, Pratt RH, Price SF, Tsang CA, Self JL. Tuberculosis - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:409–14. 10.15585/mmwr.mm7012a1 - DOI - PMC - PubMed
    1. World Health Organization. Global tuberculosis report 2021. [cited 2022 Apr 27]. https://www.who.int/publications/i/item/9789240037021
    1. Blecker S, Jones SA, Petrilli CM, Admon AJ, Weerahandi H, Francois F, et al. Hospitalizations for chronic disease and acute conditions in the time of COVID-19. JAMA Intern Med. 2021;181:269–71. 10.1001/jamainternmed.2020.3978 - DOI - PMC - PubMed
    1. Nabity SA, Fong V, Keh C, Flood J. Disruptions to TB program services and capacity during the COVID-19 response in California, January 2020–August 2021. In: Abstracts of the National TB Controllers Association/California TB Controllers Association Conference, 2022. Palm Springs, CA, USA; 2022 May 23–26. Smyrna (GA): National TB Controllers Association; 2022.
    1. Nabity SA, Han E, Lowenthal P, Henry H, Okoye N, Chakrabarty M, et al. Sociodemographic characteristics, comorbidities, and mortality among persons diagnosed with tuberculosis and COVID-19 in close succession in California, 2020. JAMA Netw Open. 2021;4:e2136853. 10.1001/jamanetworkopen.2021.36853 - DOI - PMC - PubMed